| | CASMASCI | progen | BOC | 進(jìn)口現(xiàn)貨產(chǎn)品 | 胎牛血清 | 細(xì)胞培養(yǎng) | 提取試劑 | 轉(zhuǎn)染試劑 | 常規(guī)生化試劑 | ELISA試劑盒 | 抗體 | 細(xì)胞因子 | sigma aldrich(西格瑪) | Invitrogen(英駿) | Millipore | Abcam | CST | Roche | peprotech | prospec | pierce | BD Pharmingen | BD Biocoat | R&D | BioVision | Vector | Enzo life | eBioscience | ABR | Amresco | Cayman Chemical | 脂蛋白 | Merck | Qiagen(凱杰) | Santa cruz(三塔抗體) |
產(chǎn)品名稱:PE aGalCer-mouse CD1d (clone L363), 100 ug
產(chǎn)品貨號:eBioscience 12-2019-82
產(chǎn)品規(guī)格:100 ug
Anti-Mouse alpha GalCer:CD1d Complex PE
Also known as: alpha GalCer-CD1d complex, alphaGalCerCD1d complex, alpha galcer-CD1d complex, alpha-galactosylceramide, alpha galactosylceramide, CD1d
Clone: L363
RUO: For Research Use Only. Not for use in diagnostic procedures.
SKU# 12-2019
Cat. No. Size
12-2019-80 25 ug
12-2019-82 100 ug
Description: This L363 monoclonal antibody reacts with α-galactosylceramide bound to the mouse MHC class I-like protein CD1d. This complex is recognized by invariant natural killer T (iNKT) cells, a subset of T lymphocytes that expresses the invariant TCR α chain Vα14Jα18. Activation of iNKT cells leads to production of Th1 and Th2-associated cytokines as well as dendritic cell maturation.
The L363 antibody has been reported to neutralize iNKT cell activation by α-galactosylceramide:CD1d complexes.